GlassScriptPhysician profile
Cassie L Johnson
NPI 1972907038
$1,452.18
in general payments reported to CMS, 2019-2025
9 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $182 · 2023: $206 · 2024: $632 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $799.38 | 2021-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $306.89 | 2024 | Senza |
| Globus Medical, INC. | $93.86 | 2025 | Senza |
| Abbott Laboratories | $71.73 | 2024-2025 | Eterna |
| Medtronic, INC. | $66.88 | 2025 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $47.94 | 2025 | Sprint Pns System |
| Vertos Medical, INC. | $27.35 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $22.91 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $15.24 | 2023 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassie Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.